Advertisement

Atrial Fibrillation

Survey of clinical practice pattern in Germany's certified chest pain units : Adherence to the European Society of Cardiology guidelines on non-ST-segment elevation acute coronary syndrome.

Nov 15, 2021

We aimed to analyze the 2020 standard of care in certified German chest pain units (CPU) with a special focus on non-ST-segment elevation acute coronary syndrome (NSTE-ACS) through a voluntary surve...

Predicting patient-level new-onset atrial fibrillation from population-based nationwide electronic health records: protocol of FIND-AF for developing a precision medicine prediction model using artificial intelligence.

Nov 08, 2021

Atrial fibrillation (AF) is a major cardiovascular health problem: it is common, chronic and incurs substantial healthcare expenditure because of stroke. Oral anticoagulation reduces the risk of throm...

Intravenous Metoprolol Versus Diltiazem for Rate Control in Atrial Fibrillation.

Nov 08, 2021

Currently, it remains unclear whether β-blockers or nondihydropyridine calcium channel blockers are preferred for the acute management of atrial fibrillation (AF).The objective of this study was to c...

Atrial High-Rate Event Incidence and Predictors in Patients With Permanent Pacemaker Implantation.

Nov 01, 2021

The present study aims to investigate the incidence and predictors of atrial high-rate events (AHREs) in patients with permanent pacemaker implants. A total of 289 patients who were implanted with a...

Attenuating persistent sodium current induced artial myopathy and fibrillation by preventing mitochondrial oxidative stress.

Nov 01, 2021

Mechanistically driven therapies for atrial fibrillation (AF), the most common cardiac arrhythmia, are urgently needed, the development of which require improved understanding of the cellular signalin...

Automatic Mobile Health Arrhythmia Monitoring for the Detection of Atrial Fibrillation: Prospective Feasibility, Accuracy, and User Experience Study.

Oct 25, 2021

Atrial fibrillation (AF) is the most common tachyarrhythmia and associated with a risk of stroke. The detection and diagnosis of AF represent a major clinical challenge due to AF's asymptomatic and in...

Prospective randomised trial examining the impact of an educational intervention versus usual care on anticoagulation therapy control based on an SAMe-TTR score-guided strategy in anticoagulant-naïve Thai patients with atrial fibrillation (TREATS-AF): a study protocol.

Oct 18, 2021

The burden of atrial fibrillation (AF) in Thailand is high and associated with increased morbidity, mortality and healthcare costs. Vitamin K antagonists (eg, warfarin), commonly used for stroke preve...

Why Did All Patients with Atrial Fibrillation and High Risk of Stroke Not Receive Oral Anticoagulants? Results of the Polish Atrial Fibrillation (POL-AF) Registry.

Oct 18, 2021

Most atrial fibrillation (AF) patients are at high risk of thromboembolic, and the use of oral anticoagulants (OACs) is advised in such cases. The aim of the study was to evaluate the frequency at whi...

Red blood cell distribution width in elderly hospitalized patients with cardiovascular disease.

Oct 11, 2021

Red blood cell distribution width (RDW) is elevated in patients with cardiovascular disease (CVD).To determine RDW values and impact of CV and non-CV coexisting morbidities in elderly patients hospita...

De Novo vs Acute-on-Chronic Presentations of Heart Failure-Related Cardiogenic Shock: Insights from the Critical Care Cardiology Trials Network Registry.

Oct 11, 2021

Heart failure-related cardiogenic shock (HF-CS) accounts for an increasing proportion of cases of CS in contemporary cardiac intensive care units. Whether the chronicity of HF identifies distinct clin...

[Atrial fibrillation-Syndromic phenotype in HFpEF or primary disease?]

Oct 04, 2021

Atrial fibrillation and heart failure with preserved left ventricular (LV) ejection fraction (HFpEF) are of high importance in cardiology due to the increasing number of cases. Both diseases can mutua...

A drug utilization study of oral anticoagulants in five representative cities of China between 2015 and 2019.

Oct 04, 2021

Oral anticoagulants (OACs), including warfarin and newer direct-acting OACs (DOACs), have been used for decades to prevent thromboembolic diseases. A drug utilization study was performed to determine ...

Retrospective cohort study of new-onset atrial fibrillation in acute pulmonary embolism on prognosis.

Sep 27, 2021

To investigate the characteristics of new-onset atrial fibrillation (AF) and its impact on prognosis in acute pulmonary embolism (aPE).A retrospective cohort study SETTING: The study cohort included p...

Time in therapeutic range values of patients using warfarin and factors that influence time in therapeutic range.

Sep 20, 2021

The time in therapeutic range (TTR) of international normalized ratio (INR) is essential for the safety and efficacy of warfarin treatment. In this study, we aimed to determine TTR and the factors tha...

Telemonitoring of Real-World Health Data in Cardiology: A Systematic Review.

Sep 13, 2021

New sensor technologies in wearables and other consumer health devices open up promising opportunities to collect real-world data. As cardiovascular diseases remain the number one reason for disease a...

Medication adherence to direct anticoagulants in patients with non-valvular atrial fibrillation - A real world analysis.

Sep 13, 2021

Direct oral anticoagulants (DOACs) changed the landscape of atrial fibrillation (AF) treatment, but also brought with them new challenges in terms of accessibility and compliance. The purpose of this ...

Echocardiographic Findings in Patients with Atrial Fibrillation in a Tertiary Care Center of Nepal: A Descriptive Cross-sectional Study.

Sep 13, 2021

Atrial fibrillation is the most prevalent supraventricular arrhythmia responsible for the large morbidity and mortality burden worldwide. There are various causes of atrial fibrillation that may affec...

Direct Oral Anticoagulants Versus Warfarin for Treatment of Thrombosis or Atrial Fibrillation in Patients With Cirrhosis: A Retrospective Cohort Study.

Sep 06, 2021

Evidence for direct oral anticoagulants (DOACs) in patients with cirrhosis is limited. Few patients with Child-Turcotte-Pugh (CTP) class B and C cirrhosis have been studied.To compare major bleeding r...

Assessment of patients with a suspected cardioembolic ischemic stroke. A national consensus statement.

Sep 06, 2021

Several cardiovascular, structural, and functional abnormalities have been considered as potential causes of cardioembolic ischemic strokes. Beyond atrial fibrillation, other sources of embolism clear...

Examination of anticoagulation prescription among elderly patients with atrial fibrillation after in-hospital fall.

Sep 06, 2021

Mechanical fall is common among elders and has been associated with a lack of anticoagulant therapy among patients with atrial fibrillation (AF). However, anticoagulant therapy is recommended despite ...